Charles River Laboratories International, Inc. CRL
Super Investor & Insider
3
Fondi che lo detengono
#273
Rank consenso
4.3%
% dei portafogli
$622.0M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Bill Nygren · Harris Associates | 0.5% | Add 28.36% | 2,153,296 | $371.4M |
| John Rogers · Ariel Investments | 2.79% | Add 1.15% | 1,444,183 | $249.1M |
| Lee Ainslie · Maverick Capital | 0.02% | Buy | 8,178 | $1.4M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Charles River Laboratories International, Inc. is a leading provider of essential products and services that support pharmaceutical, biotechnology, and medical device companies in drug discovery, development, and manufacturing. It operates through three core segments: Research Models and Services, which supplies specia…
SectorHealthcare
ExchangeNYSE
IndustryDiagnostics & Research
CountryUnited States
Employees18,700
TickerCRL
Statistics
Market Cap$8.79B
Revenue (TTM)$4.02B
Net Income-$142.2M
Net Margin-3.5%
EPS$-2.91
P/E681.33
P/S2.25
P/B3.08
EV/EBITDA13.37
ROE-5.9%
Dividend Yield0.64%
Price$182.41
Data: Twelve Data · Revenue = mcap / P/S